ArticlePharmaceutics2026
Synergistic Cancer Immunotherapy by Inducing Immunogenic Cell Death and Blocking the CD39-Adenosine Pathway Using a Nanoplatform.
Yiwen Liu, Xiaoyu Pang, Lin Li, Lele Li, Hongzhang Deng, Dingjun Zha
Abstract read
In one paragraphArticle in Pharmaceutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
6 authors.
Yiwen LiuDepartment of Otolaryngology-Head and Neck Surgery, Xijing Hospital, Air Force Medical University, Xi'an 710032, China.
Xiaoyu PangSchool of Life Science and Technology, Engineering Research Center of Molecular and Neuro Imaging, Ministry of Education, Xidian University, Xi'an 710126, China.
Lin LiSchool of Life Science and Technology, Engineering Research Center of Molecular and Neuro Imaging, Ministry of Education, Xidian University, Xi'an 710126, China.
Lele LiDepartment of Otolaryngology-Head and Neck Surgery, Xijing Hospital, Air Force Medical University, Xi'an 710032, China.
Hongzhang DengSchool of Life Science and Technology, Engineering Research Center of Molecular and Neuro Imaging, Ministry of Education, Xidian University, Xi'an 710126, China.ORCID 0000-0003-3637-8905 Dingjun ZhaDepartment of Otolaryngology-Head and Neck Surgery, Xijing Hospital, Air Force Medical University, Xi'an 710032, China.ORCID 0000-0002-9380-9209 Funding
First Affiliated Hospital of Henan University of Science and Technology ZLKFJJ20230513Major Scientific and Technological Innovation Project-Major Scientific and Technological Achievement Transformation Project (Integrated Project of 'Education, Science and Technology, and Talent') of Xianyang S2025-ZDKJ-ZDCGZH-4508National Key R&D Program of China 2024YFA1212500National Natural Science Foundation of China projects 82571312Natural Science Foundation of Shaanxi Province 2025JC-QYCX-066Shaanxi Provincial Science and Technology Research Fund 2024SF ZDCYL-01-16Xijing Hospital XJZT24CZ01
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
adenosineATPCD39combined therapyimmunogenic cell deathimmunosuppressionnanoparticles
Identifiers
PMID42514914
PMCPMC13416026
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390